Key result
Novel rehabilitation trials recruit ~1,500 diverse patients despite pandemic interruptions and low baseline interest.
Why the study?
In the United States, only approximately 30% of eligible patients enroll in cardiac rehabilitation and 3-4% enroll in pulmonary rehabilitation despite class I guideline recommendations. This report updates study-specific demographics and summarizes recruitment challenges across six NIH-funded phase two clinical trials testing strategies to increase rehabilitation use and reduce disparities.
What are the baseline demographics and barriers to recruitment across six NIH-funded phase two clinical trials testing novel delivery strategies to increase cardiac and pulmonary rehabilitation participation?
What are the baseline demographics and barriers to recruitment across six NIH-funded phase two clinical trials testing novel delivery strategies to increase cardiac and pulmonary rehabilitation participation?
Answers are grounded in this paper and cite their sources.
This report demonstrates that despite severe COVID-19 disruptions and high refusal rates in pulmonary rehabilitation, six NIH-funded trials successfully recruited 1,548 patients with high representation of women, Black patients, and lower-SES individuals using alternative delivery models such as telehealth, home-based rehabilitation, and behavioral incentives.
cardiac rehabilitation; pulmonary rehabilitation; health disparitiesIn the United States, approximately 30% of patients who qualify for cardiac rehabilitation (CR) enroll 1 and only about 3-4% of patients eligible for pulmonary rehabilitation (PR) enroll, 2 despite both programs representing a class I guideline-recommended treatment strategy.In 2018, the National Heart, Lung, and Blood Institute and the National Institute of Aging funded four CR and two PR phase two clinical trials to address the following issues: (a) test strategies that will lead to increased use of CR and PR in the United States population who are eligible based on clinical guidelines, (b) reduce disparities in the use of CR and PR based on age, sex, race/ethnicity, and socioeconomic status (SES); and (c) test whether increased use of CR and PR, whether by traditional center-based or new models, is accompanied by improvements in relevant clinical and patient-centered outcomes, including exercise capacity, cardiovascular and pulmonary risk factors, and quality of life.
No takes yet. Share an insight, caveat, or question.
Grimshaw et al. (2023) conducted a review in Patients eligible for cardiac rehabilitation or pulmonary rehabilitation (n=1,548). Non-traditional cardiac and pulmonary rehabilitation delivery models (hybrid/telehealth, home-based, coaching, behavioral nudges, and financial incentives) vs. Traditional center-based rehabilitation or usual care was evaluated on Recruitment, enrollment, adherence, and completion of cardiac and pulmonary rehabilitation. Across six NIH-funded rehabilitation trials, 1,548 diverse patients were recruited despite COVID-19 interruptions and low baseline interest.
Synapse has enriched 10 related papers. Consider them for comparative context: